신종합성 마약류의 분자도킹을 통한 의존성 예측평가
Evaluation of Addictive Prediction through Molecular Docking of Designer Drugs
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
본 연구에서는 임시마약류로 지정된 15종의 amphetamine (1-15)류 화합물들에 대해 molecular docking 기법을 사용하여 도파민 수송체에 대한 docking total score 값을 계산하고 이를 통해 수용체와의 binding affinity를 예측하였으며 화합물들간의 구조적 특성을 비교하였다. 그 결과, cathinone (3) 유도체 중 하나인 naphyrone (15)의 total score가 8.083으로 가장 높은 값을 보였다. 그리고 amphetamine 류 화합물들은 binding site의 아미노산 잔기사이에 Van der Waals 상호작용과 수소결합의 상호작용이강하게 일어남을 확인하였을 뿐 아니라, lipophilicity (ClogP)에 대하여 매우 높은 상관관계가 존재함을알았다. 이러한 결과는 다양하게 설계된 합성마약류들이 빠르게 확산될 수 있음을 시사하며 본 연구에서 수행한 in silico 기법이 신종 합성마약에 대한 생리활성평가법의 단점을 보완한 신종합성마약류 확산 방지를 위한 제도 마련의 근거가 되고자 한다.
Abstract
In this study, the docking total score for dopamine transporter was calculated by molecular docking technique using the 15 kinds of amphetamine compounds (1-15) designated as temporary drugs. From this, the binding affinity to the receptor was predicted and the structural characteristics of the compounds were compared. The total score of Naphyrone (15), one of the Cathinone (3) derivatives, was the highest at 8.083. Amphetamine compounds were found to be highly correlated with lipophilicity (ClogP) as well as confirming that the Van der Waals and the hydrogen bond interaction were strongly induced between the amino acid residues of the binding site. These results imply that various designer drugs can be rapidly diffused, and the in silico technique performed in this study is intended to be a basis for the establishment of a system to prevent the spread of new designer drugs, which complements the disadvantages of the method for evaluating physiological activity against new designer drugs.
참고문헌 (23)
- J Fratantonio, "Designer Drugs : A Synthetic Catastrophe", J Reward Defic Syndr, 1, pp.82~86 (2015)
- 신명희, "마약류 지정 제도의 개선-임시지정제도와 아날로그 제도의 도입", 한국에프디시법제학회, 7, pp.13~19 (2012)
- Methiopropamine Critical Review Report, "Agenda item", WHO, 1~18 (2016)
- L Simmler, "Pharmacological characterization of designer cathinones in vitro", Br J Pharmacol, 168, pp.458~470 (2013)
- 약물의존성 발생에서의 도파민 수송체의 역할, "이용선", 보건복지부, ~ (2014)
- 김명옥, "도파민과 GABA 신경전달물질에 대한 연구 : 중독유발물질에 의한 이상분비", 한국동물학회, 18, pp.12~20 (2001)
- Guidance Document, "Clinical assessment of abuse liability for drugs with central nervous system activity" (2007), Health Canada
- H June, "Operant self-administration models for testing the neuropharmacological basis of ethanol consumption in rats", Curr Protoc Neurosci, 9, pp.1226~1257 (2010)
- 윤재석, "합성마약류의 의존성 평가를 위한 구조활성상관(QSAR) 모델 적용", 약 학 회 지, 58(1), pp.53~57 (2014), 대한약학회
- 이상훈, "코카인 결함과 관련된 도파민 수송체의 아미노산 구조", 약학회지, 43, pp.743~750 (1999)
- M Kurihara, "Computational study on prediction of bioactivity for regulation of new designer drugs", Yakugaku Zasshi, 133, pp.13~16 (2013)
- 임시 마약류에 대한 의존성 평가 연구, "성균관대학교 산학협력단", 식품의약품안전처, ~, pp.최종보고서 1-58 (2013)
- M Baier, "Tripodands with Phenyl and Thiophenyl Rings and Nitrogen Bridgehead Atoms", Eur J Org Chem, 23, pp.5264~5278 (2006)
- "SYBYL-X version 1.3", Tripos International, ~
- K Wang, "Neurotransmitter and psychostimulant recognition by the dopamine transporter", Nature, 521, pp.322~327 (2015)
- C Hansch, "Substituent constants for correlation analysis in chemistry and biology" (1979), Wiley interscience New York
- D Kitchen, "Docking and scoring in virtual screening for drug discovery : methods and applications", Nat Rev Drug Discov, 3, pp.935~949 (2004)
- M Murcko, "Computational Methods to Predict Binding Free Energy in Ligand-Receptor Complexes", J Med Chem, 38, pp.4953~4967 (1995)
- M Feig, "Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures", J Com Chem, 25, pp.265~284 (2004)
- M Waldherr-Teschner, "MOLCAD-Computer Aided Visualization and Manipulation of Models in Molecular Science", Adv Sci Vis, pp.58~67 (1992)
- C Lipinski, "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings", Adv Drug Deliv Rev, 46, pp.3~26 (2001)
- C Lipinski, "Lead-and drug-like compounds : the rule-of-five revolution", Drug Discov Today Technol, 1, pp.337~341 (2004)
- H Dixon, "Nomenclature and Symbolism for Amino Acids and Peptides", Eur J Biochem, 138, pp.9~37 (1984)
